Author:
Freyburger Geneviève,Macouillard Gérard,Labrouche Sylvie,Sztark François
Reference31 articles.
1. RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty;Eriksson;N Engl J Med,2008
2. RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial;Kakkar;Lancet,2008
3. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty;Lassen;N Engl J Med,2008
4. Turpie AG, Bauer KA, Davidson B, Comparison of rivaroxaban, an oral direct factor Xa inhibitor, and subcutaneous enoxaparin for thromboprophylaxis after total knee replacement (RECORD 4: a phase III study), Proceedings of the 9th EFORT Congress, Nice, May 30, 2008 Abst F85. Published in the Journal of Bone and Joint Surgery - British Volume, Vol 92-B, Issue SUPP_II, 329. Copyright © 2010 by British Editorial Society of Bone and Joint Surgery.
5. RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, noninferiority trial;Eriksson;Lancet,2007
Cited by
145 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献